Advanced Ovarian Carcinoma

Oncology
2
Pipeline Programs
2
Companies
2
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Alliance Pharmaceuticals
1 program
1
Biospecimen CollectionPhase 11 trial
Active Trials
NCT07144826Recruiting161Est. Jul 2027
Molecure
MolecurePoland - Warsaw
1 program
1
OATD-02Phase 11 trial
Active Trials
NCT05759923RecruitingEst. Dec 2025

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
Alliance PharmaceuticalsBiospecimen Collection
MolecureOATD-02

Clinical Trials (2)

Total enrollment: 161 patients across 2 trials

Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy

Start: Mar 2026Est. completion: Jul 2027161 patients
Phase 1Recruiting

First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours

Start: Jan 2023Est. completion: Dec 2025
Phase 1Recruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 161 patients
2 companies competing in this space